![Matthew Lettunich](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Matthew Lettunich
Director de Operaciones en Blackfly Investments LLC .
Perfil
Matthew Lettunich has worked as an Operations Manager at Blackfly Investments LLC since 2018.
Cargos activos de Matthew Lettunich
Empresas | Cargo | Inicio |
---|---|---|
Blackfly Investments LLC
![]() Blackfly Investments LLC Miscellaneous Commercial ServicesCommercial Services Blackfly Investments LLC is the parent company of Molecular Testing Labs, a CLIA-certified and CAP-accredited laboratory that aims to make diagnostic testing more accessible and affordable through research and development, logistics, and proprietary technology systems. The private company is based in Vancouver, WA. The company partner with various organizations, including retailers, pharmacies, universities, and healthcare facilities, to provide laboratory solutions and convenient collection kits for non-clinically collected samples. The company was founded by Peter Flynn, Adam Blackwell, and James York. Eric D. Strafel has been the CEO of the company since 2022. | Director de Operaciones | 01/07/2018 |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 1 |
---|---|
Blackfly Investments LLC
![]() Blackfly Investments LLC Miscellaneous Commercial ServicesCommercial Services Blackfly Investments LLC is the parent company of Molecular Testing Labs, a CLIA-certified and CAP-accredited laboratory that aims to make diagnostic testing more accessible and affordable through research and development, logistics, and proprietary technology systems. The private company is based in Vancouver, WA. The company partner with various organizations, including retailers, pharmacies, universities, and healthcare facilities, to provide laboratory solutions and convenient collection kits for non-clinically collected samples. The company was founded by Peter Flynn, Adam Blackwell, and James York. Eric D. Strafel has been the CEO of the company since 2022. | Commercial Services |
- Bolsa de valores
- Insiders
- Matthew Lettunich